Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Is a |
Product containing buprenorphine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Is a |
Buprenorphine product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Is a |
Product containing buprenorphine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opiate agonist-antagonist |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with opioid receptor partial agonist mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Buprenorphine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Is a |
Product containing buprenorphine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
buprénorphine 300 microgrammes/mL, ampoule de 1 mL de solution pour injection |
Has manufactured dose form |
Injection solution (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|